Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP Study)
An Assessor-blinded, Randomized, 20-week, Parallel-group, Superiority Study to Compare the Efficacy of Transdiagnostic Cognitive Behavioral Therapy Versus Waiting-list in Depressive and Anxiety Symptoms of Depressive and Anxiety Disorders
Sponsor: National Center of Neurology and Psychiatry, Japan
Listed as NCT02003261, this NA trial focuses on Anxiety Disorders and Depressive Disorders and remains completed. Sponsored by National Center of Neurology and Psychiatry, Japan, it has been updated 7 times since 2014, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE3 → NA
-
Jul 2018 — Sep 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 2 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Center of Neurology and Psychiatry, Japan
For direct contact, visit the study record on ClinicalTrials.gov .